国际妇产科学杂志
國際婦產科學雜誌
국제부산과학잡지
Journal Of International Obstetrics And Gynecology
2015年
5期
520-523
,共4页
糖尿病,妊娠%生物学标记%C反应蛋白质%性激素结合球蛋白%肾素%纤连蛋白类%加兰肽
糖尿病,妊娠%生物學標記%C反應蛋白質%性激素結閤毬蛋白%腎素%纖連蛋白類%加蘭肽
당뇨병,임신%생물학표기%C반응단백질%성격소결합구단백%신소%섬련단백류%가란태
Diabetes,gestational%Biological markers%C -reactive protein%Sex hormone -binding globulin%Renin%Fibronectins%Galanin
妊娠期糖尿病(GDM)是妊娠期重要的并发症之一。 GDM对孕产妇及围生儿均有较大危害:孕妇易并发妊娠期高血压疾病、胎膜早破、产后出血等,孕妇产后发生2型糖尿病的概率增加,胎儿巨大儿的发生率和畸形率高,新生儿窒息和低血糖发生率高,新生儿成年后罹患代谢性疾病及肥胖的概率增高。目前临床上GDM筛查是在孕24~28周通过糖耐量实验进行的。但对于孕早期患GDM的孕妇目前尚无很好的技术进行检测。随着GDM患者的不断增多,早期筛查越来越引起重视。目前已开展了关于GDM早期预测标记物的研究,这些预测标记物主要包括超敏C反应蛋白、性激素结合球蛋白、可溶性肾素/肾素原受体、糖基化纤连蛋白和甘丙肽等,对这些标记物的基本性质及其在预测GDM时的效果等方面的研究进展进行综述。
妊娠期糖尿病(GDM)是妊娠期重要的併髮癥之一。 GDM對孕產婦及圍生兒均有較大危害:孕婦易併髮妊娠期高血壓疾病、胎膜早破、產後齣血等,孕婦產後髮生2型糖尿病的概率增加,胎兒巨大兒的髮生率和畸形率高,新生兒窒息和低血糖髮生率高,新生兒成年後罹患代謝性疾病及肥胖的概率增高。目前臨床上GDM篩查是在孕24~28週通過糖耐量實驗進行的。但對于孕早期患GDM的孕婦目前尚無很好的技術進行檢測。隨著GDM患者的不斷增多,早期篩查越來越引起重視。目前已開展瞭關于GDM早期預測標記物的研究,這些預測標記物主要包括超敏C反應蛋白、性激素結閤毬蛋白、可溶性腎素/腎素原受體、糖基化纖連蛋白和甘丙肽等,對這些標記物的基本性質及其在預測GDM時的效果等方麵的研究進展進行綜述。
임신기당뇨병(GDM)시임신기중요적병발증지일。 GDM대잉산부급위생인균유교대위해:잉부역병발임신기고혈압질병、태막조파、산후출혈등,잉부산후발생2형당뇨병적개솔증가,태인거대인적발생솔화기형솔고,신생인질식화저혈당발생솔고,신생인성년후리환대사성질병급비반적개솔증고。목전림상상GDM사사시재잉24~28주통과당내량실험진행적。단대우잉조기환GDM적잉부목전상무흔호적기술진행검측。수착GDM환자적불단증다,조기사사월래월인기중시。목전이개전료관우GDM조기예측표기물적연구,저사예측표기물주요포괄초민C반응단백、성격소결합구단백、가용성신소/신소원수체、당기화섬련단백화감병태등,대저사표기물적기본성질급기재예측GDM시적효과등방면적연구진전진행종술。
Gestational diabetes mellitus(GDM) is one of the most important complications emerging at pregnancy. Women diagnosed with GDM is characterized by increased risk of various fetal and maternal complications which include gestational hypertension disease, premature rupture of membranes, postpartum hemorrhage and developing type Ⅱ diabetes mellitus after childbirth. At the same time, the babies are at higher risk of fetal macrosomia and deformity, neonatal asphyxia and neonatal hypoglycemia, and suffering from metabolic diseases and obesity after reaching adulthood. The routine screening for GDM begins at 24-28 weeks with a glucose challenge test. But a test method for GDM detection at the first-trimester is still lacking. With the increasing of GDM patients, early screening is getting more and more attention. Over the years, several scientists reported their new findings on early predictors of GDM. The new predictors include high-sensitivity C-reactive protein, sex hormone binding globulin, soluble pro-renin receptor, glycosylated fibronectin and galanin. This review is focused on summarizing the recent advances of these five potential predictors.